ETF PRO AIOctober 2, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · October 2, 2026
ONE YEAR OF DAILY CLOSES
0.58%expense ratio
$424Mfund assets
+15.8%return, YTD
+32.8%return, 1 year
−$50Mnet flow, 1 month
+$114Mnet flow, 1 year
18.9%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | NTRA NATERA | 6.24% |
| 2 | ILMN ILLUMINA | 6.13% |
| 3 | BIIB BIOGEN | 5.22% |
| 4 | GILD GILEAD SCIENCES | 5.16% |
| 5 | RPRX ROYALTY PHARMA | 4.76% |
| 6 | AMGN AMGEN | 4.86% |
| 7 | VRTX VERTEX PHARMACEUTICALS | 4.83% |
| 8 | REGN REGENERON PHARMACEUTICALS | 4.57% |
| 9 | MRNA MODERNA | 3.54% |
| 10 | NVAX NOVAVAX | 3.17% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS